These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 2295475)

  • 1. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
    Powell EE; Cooksley WG; Hanson R; Searle J; Halliday JW; Powell LW
    Hepatology; 1990 Jan; 11(1):74-80. PubMed ID: 2295475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases from the spectrum of nonalcoholic steatohepatitis.
    Abdelmalek M; Ludwig J; Lindor KD
    J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.
    Pinto HC; Baptista A; Camilo ME; Valente A; Saragoça A; de Moura MC
    Dig Dis Sci; 1996 Jan; 41(1):172-9. PubMed ID: 8565753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).
    Hussein O; Grosovski M; Schlesinger S; Szvalb S; Assy N
    Dig Dis Sci; 2007 Oct; 52(10):2512-9. PubMed ID: 17404856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.
    Struben VM; Hespenheide EE; Caldwell SH
    Am J Med; 2000 Jan; 108(1):9-13. PubMed ID: 11059435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
    Ludwig J; Viggiano TR; McGill DB; Oh BJ
    Mayo Clin Proc; 1980 Jul; 55(7):434-8. PubMed ID: 7382552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
    Fassio E; Alvarez E; Domínguez N; Landeira G; Longo C
    Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late nonalcoholic fatty liver disease with cirrhosis: a pathologic case of lost or mistaken identity.
    Lefkowitch JH; Morawski JL
    Semin Liver Dis; 2012 Feb; 32(1):92-8. PubMed ID: 22418891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute liver failure in obese women.
    Caldwell SH; Hespenheide EE
    Am J Gastroenterol; 2002 Aug; 97(8):2058-62. PubMed ID: 12190177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and hepatocellular carcinoma.
    Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease in patients investigated for elevated liver enzymes.
    Kichian K; McLean R; Gramlich LM; Bailey RJ; Bain VG
    Can J Gastroenterol; 2003 Jan; 17(1):38-42. PubMed ID: 12560853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS.
    Castro PCS; Alberton HCP; Pedroso MLA; Morsoletto DBG; Pissaia Junior A; Ivantes CAP
    Arq Gastroenterol; 2019; 56(3):256-260. PubMed ID: 31633721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver pathology in obesity.
    Suriawinata A; Fiel MI
    Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
    Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
    Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.